Metabolic results 3 years after simultaneous pancreas-kidney transplantation

Nephrology Dialysis Transplantation

Volumn 20, Issue SUPPL. 2, 2005, Pages

  Secchi, Antonio ^a   Malaise, Jacques ^b   Caldara, Rossana ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Amylase; Blood lipids; Glucose metabolism; Lipase; Simultaneous pancreas kidney transplantation; Type 1 diabetes

Indexed keywords

AMYLASE; ANTIHYPERTENSIVE AGENT; C PEPTIDE; CHOLESTEROL; CYCLOSPORIN; GLUCOSE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ACUTE GRAFT REJECTION; AMYLASE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE MONITORING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG RESPONSE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; KIDNEY TRANSPLANTATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC DISORDER; METABOLIC PARAMETERS; MICROEMULSION; PANCREAS TRANSPLANTATION; PANCREATITIS; POPULATION RESEARCH; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

AMYLASES; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; EUROPE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISRAEL; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIPASE; LIPIDS; PANCREAS TRANSPLANTATION; POSTOPERATIVE PERIOD; TIME FACTORS;

EID: 18844419732     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh1078     Document Type: Article

References (25)

1. Kaufman DB. Pancreas transplantation. In: Stuart FP, Abecassis MM, Kaufman DB, eds. Organ Transplantation. Landes Bioscience, Texas; 2000: 145-168
2. Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) cases reported to the United Network for Organ Sharing (UNOS) and non-US cases reported to the International Pancreas Transplant Registry (IPTR) as of October 2000. Clin Transplant 2000: 45-72
3. Troppmann C, Gruessner AC, Benedetti E et al. Vascular graft thrombosis after pancreas transplantation: univariate and multivariate operative and nonoperative risk factor analysis. J Am Coll Surg 1996; 182: 285-316
4. Gruessner RWG, Sutherland DER. Pancreas transplantation II: the recipient operation. Surg Rounds 1994; 17: 383-391
5. Gruessner RW, Troppmann C, Barrou B et al. Assessment of donor and recipient risk factors on pancreas transplant outcome. Transplant Proc 1994; 26: 437-438
6. Luzi L, Picena Sereni L, Battezzati A, Elli A, Soulillou JP, Cantarovich D. Metabolic effects of a corticosteroid-free immunosuppressive regimen in recipients of pancreatic transplant. Transplantation 2003; 75: 2018-2023
7. Odorico JS, Sollinger HW. Technical and immunosuppressive advances in transplantation for insulin-dependent diabetes mellitus. World J Surg 2002; 26: 194-211
8. Bechstein WO, Malaise J, Saudek F et al. Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial. Transplantation 2004; 77: 1221-1228
9. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-1053
10. Scott LJ, McKeage K, Keam SJ, Plosker GL. Tacrolimus. A further update of its use in the management of organ transplantation. Drugs 2003; 63: 1247-1297
11. Rostaing L, Catarovich D, Mourad G, Neumayer H-H, Rigotti P, the CARMEN Study Group. Steroid-free immunosuppression with a combination of daclizumab, tacrolimus and MMF is efficacious and safe: results of a large multicentre trial in renal transplantation. Am J Transplant 2003; 3 [Suppl 5]: 312 [abstract 627]
12. Seechi A, Caldara R, Caumo A et al. Cephalic-phase insulin and glucagon release in normal subjects and in patients receiving pancreas transplantation. Metabolism 1995; 44: 1153-1158
13. Luzi L, Battezzati A, Perseghin G et al. Lack of feedback inhibition of insulin secretion in denervated human pancreas. Diabetes 1992; 41: 1632-1639
14. Battezzati A, Benedini S, Caldara R et al. Prediction of the long-term metabolic success of the pancreatic graft function. Transplantation 2001; 71: 1560-1565
15. Hirano T, Manabe T, Printz H, Tobe T. Cytotoxic effects of cyclosporin A on the exocrine pancreas in rats. Surg Gynecol Obstet 1992; 175: 495-500
16. Hirano T, Manabe T, Ando K, Tobe T. Acute cytotoxic effect of cyclosporin A on pancreatic acinar cells in rats. Protective effect of synthetic protease inhibitor E3123. Scand J Gastroenterol 1992; 27: 103-107
17. Ito T, Kimura T, Yamaguchi H et al. Acute pancreatitis induced by cyclosporin A under stimulation of pancreas by caerulein. Pancreas 1993; 8: 693-699
18. Yamada T, Hashimoto T, Sogawa M et al. Role of T cells in development of chronic pancreatitis in male Wistar Bonn/Kobori rats: effects of tacrolimus. Am J Physiol 2001; 281: G1397-G1404
19. Mayer JM, Laine VJ, Gezgin A et al. Single doses of FK506 and OKT3 reduce severity in early experimental acute pancreatitis. Eur J Surg 2000; 166: 734-741
20. Fellström B. Risk factors for and management of post-transplantation cardiovascular disease. BioDrugs 2001; 15: 261-278
21. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002; 346: 580-590
22. Krämer BK, Zülke C, Kammerl MC et al. Cardiovascular risk factors and estimated risk for CAD in a randomized trial comparing calcineurin inhibitors in renal transplantation. Am J Transplant 2003; 3: 982-987
23. Schang T, Timmermann W, Thiede A, Najarian JS, Sutherland DE. Detrimental effects of fluid and electrolyte loss from duodenum in bladder-drained pancreas transplants. Transplant Proc 1991; 23: 1617-1618
24. Hricik DE, Chareandee C,Knauss TC, Schulak JA. Hypertension after pancreas-kidney transplantation: role of bladder vs enteric pancreatic drainage. Transplantation 2000; 70: 494-496
25. La Rocca E, Gobbi C, Ciurlino D, Di Carlo V, Pozza G, Secchi A. Improvement of glucose/insulin metabolism reduces hypertension in insulin-dependent diabetes mellitus recipients of kidney-pancreas transplantation. Transplantation 1998; 64: 390-393